Kris Vaddi, PhD

Kris Vaddi, PhD

Kris Vaddi, Ph.D. is a drug discovery scientist and the founder of cancer focused startup companies Orsenix and Prelude Therapeutics, and a not-for-profit venture Sidus Healthcare. Prior to his new ventures, Kris had a 14-year career at Incyte starting as a founding...

Kelvin M. Neu

Kelvin M. Neu, M.D. was appointed a member of the Company’s Board in July 2016. Kelvin is a Managing Director of Baker Brothers Investments. The firm manages long-term investment funds focused on publicly traded life sciences companies, for major university endowments...
David Bonita

David Bonita

Dr. David Bonita, M.D., has served as a member of our board of directors since July 2016. Since June 2013, Dr. Bonita has held the position of Private Equity Partner at OrbiMed Advisors LLC, an affiliate of one of our principal shareholders. From June 2004 to June...

Paul A. Friedman

Paul Friedman, MD was appointed to the Board of Directors in July 2016. Dr. Friedman served as the Chief Executive Officer and a Director of Incyte Corporation from November 2001 until his retirement in January 2014. From 1994 to 1998, he served as President of...